DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistance
2024 · Nature Communications · 76 citations
https://doi.org/10.1038/s41467-023-44237-4
F
Fabian Meili
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
23
Papers
295
Citations
7
h-index
6
i10-index
Fabian Meili is an academic researcher from Novartis (United States). The author has contributed to research in topics: PI3K/AKT/mTOR signaling in cancer & Fungal and yeast genetics research & RNA and protein synthesis mechanisms. The author has an h-index of 7, co-authored 20 publications.
ORCID: 0000-0002-1726-4198Papers by this author
worksMulti-model functionalization of disease-associated PTEN missense mutations identifies multiple molecular mechanisms underlying protein dysfunction
2020 · Nature Communications · 62 citations
https://doi.org/10.1038/s41467-020-15943-0
Author Correction: DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistance
2024 · Nature Communications · 1 citations
https://doi.org/10.1038/s41467-024-51317-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat